OrthoPediatrics corp
KIDS
Get informed when a big investor buys or sells
+ FollowMarket Cap$518.58M
Close$
$-5.72
127.5% downside
Current Fair Value
127.5% downsideOvervalued by 127.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $518.58 Million |
|---|---|
| Enterprise Value | $554.87 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 0.99 |
| Outstanding Shares | 23,685,055 |
Return
| Return on Equity | -11.71% |
|---|---|
| Return on Assets | -7.90% |
| Return on Invested Capital | -6.95% |
Valuation & Multiples
| P/E Ratio | -12.02 |
|---|---|
| PEG | -4574.94 |
| Price to Sales | 2.08 |
| Price to Book Ratio | 1.3 |
| Enterprise Value to Revenue | 2.28 |
| Enterprise Value to EBIT | -17.56 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$68.21 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 53.10% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.95%▼ 63.92% |
|---|---|
| Total Invested | $22.41M▼ 91.34% |
| Investors Holding | 22▼ 100.00% |
ESG Score
No data
About OrthoPediatrics corp
CEO: Mark Throdahl